RY

145.75

+0.25%↑

TD

79.21

+0.53%↑

BMO

124.89

+0.05%↑

BNS

63.73

-0.41%↓

CM

80.24

+0.01%↑

RY

145.75

+0.25%↑

TD

79.21

+0.53%↑

BMO

124.89

+0.05%↑

BNS

63.73

-0.41%↓

CM

80.24

+0.01%↑

RY

145.75

+0.25%↑

TD

79.21

+0.53%↑

BMO

124.89

+0.05%↑

BNS

63.73

-0.41%↓

CM

80.24

+0.01%↑

RY

145.75

+0.25%↑

TD

79.21

+0.53%↑

BMO

124.89

+0.05%↑

BNS

63.73

-0.41%↓

CM

80.24

+0.01%↑

RY

145.75

+0.25%↑

TD

79.21

+0.53%↑

BMO

124.89

+0.05%↑

BNS

63.73

-0.41%↓

CM

80.24

+0.01%↑

Search

Hercules Capital Inc

Closed

SectorFinance

17.3 0.87

Overview

Share price change

24h

Current

Min

17.11

Max

17.32

Key metrics

By Trading Economics

Income

56M

58M

Sales

-22M

80M

P/E

Sector Avg

11.27

27.489

Dividend yield

9.58

Profit margin

72.162

Employees

100

EBITDA

45M

102M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+18.01% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

9.58%

3.99%

Next Earnings

30 paź 2025

Next Dividend date

19 lis 2025

Next Ex Dividend date

12 lis 2025

Market Stats

By TradingEconomics

Market Cap

-240M

3.1B

Previous open

16.43

Previous close

17.3

News Sentiment

By Acuity

100%

0%

506 / 530 Ranking in Finance

Technical Score

By Trading Central

Confidence

Neutral Evidence

Hercules Capital Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 paź 2025, 18:13 UTC

Major Market Movers

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 paź 2025, 17:05 UTC

Major Market Movers

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 paź 2025, 15:03 UTC

Major Market Movers

Obook Shares Sink Following Public Debut

17 paź 2025, 14:41 UTC

Major Market Movers

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 paź 2025, 23:25 UTC

Acquisitions, Mergers, Takeovers

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 paź 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 paź 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 paź 2025, 21:07 UTC

Market Talk

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 paź 2025, 21:07 UTC

Market Talk

Global Equities Roundup: Market Talk

17 paź 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 paź 2025, 20:34 UTC

Market Talk

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 paź 2025, 20:27 UTC

Market Talk

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 paź 2025, 19:46 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 paź 2025, 19:45 UTC

Market Talk

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 paź 2025, 18:45 UTC

Market Talk

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 paź 2025, 17:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 paź 2025, 17:51 UTC

Market Talk

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 paź 2025, 17:44 UTC

Market Talk

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 paź 2025, 17:35 UTC

Market Talk

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 paź 2025, 16:20 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

17 paź 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 paź 2025, 16:14 UTC

Market Talk

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 paź 2025, 16:04 UTC

Market Talk

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 paź 2025, 15:58 UTC

Market Talk

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 paź 2025, 15:56 UTC

Earnings

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 paź 2025, 15:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17 paź 2025, 15:43 UTC

Market Talk

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 paź 2025, 14:58 UTC

Market Talk

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 paź 2025, 14:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 paź 2025, 14:35 UTC

Market Talk
Earnings

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Peer Comparison

Price change

Hercules Capital Inc Forecast

Price Target

By TipRanks

18.01% upside

12 Months Forecast

Average 20.25 USD  18.01%

High 24 USD

Low 18.5 USD

Based on 5 Wall Street analysts offering 12 month price targets forHercules Capital Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

3

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

17.41 / 17.93Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat